Your Advocates Ltd’s Amgen AMGN Stock Holding History

Your Advocates Ltd’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.33K	Hold	18	–	–	﹤0.01%	141
2025 Q4	$5.89K	Hold	18	–	–	﹤0.01%	145
2025 Q3	$5.08K	Hold	18	–	–	﹤0.01%	143
2025 Q2	$5.03K	Hold	18	–	–	﹤0.01%	136
2025 Q1	$5.61K	Hold	18	–	–	﹤0.01%	133
2024 Q4	$4.69K	Hold	18	–	–	﹤0.01%	138
2024 Q3	$5.8K	Hold	18	–	–	﹤0.01%	144
2024 Q2	$5.62K	Hold	18	–	–	﹤0.01%	140
2024 Q1	$5.12K	Hold	18	–	–	﹤0.01%	145
2023 Q4	$5.18K	Hold	18	–	–	﹤0.01%	137
2023 Q3	$4.84K	Hold	18	–	–	﹤0.01%	150
2023 Q2	$4K	Buy	+18	New	+$4.18K	﹤0.01%	182

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Your Advocates Ltd's AMGN Position: Q1 2026 in Review

Your Advocates Ltd held its Amgen (AMGN) position steady in Q1 2026 at 18 shares worth $6.33K. The position accounts for ﹤0.01% of the portfolio, ranked #141.

Your Advocates Ltd first reported a position in AMGN in Q2 2023 and has held it in 12 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Your Advocates Ltd held 18 shares of Amgen worth $6.33K as of Q1 2026.
Your Advocates Ltd left its Amgen share count unchanged in Q1 2026.
Amgen made up ﹤0.01% of Your Advocates Ltd's portfolio in Q1 2026, its #141 holding.
Your Advocates Ltd first reported a position in Amgen in Q2 2023 and has held it in 12 quarters since.
3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Your Advocates Ltd's 13F filing for Q1 2026, filed 30 Apr 2026.